Suppr超能文献

恢复线粒体功能的药理学方法。

Pharmacological approaches to restore mitochondrial function.

机构信息

Laboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.

出版信息

Nat Rev Drug Discov. 2013 Jun;12(6):465-83. doi: 10.1038/nrd4023. Epub 2013 May 13.

Abstract

Mitochondrial dysfunction is not only a hallmark of rare inherited mitochondrial disorders but also implicated in age-related diseases, including those that affect the metabolic and nervous system, such as type 2 diabetes and Parkinson's disease. Numerous pathways maintain and/or restore proper mitochondrial function, including mitochondrial biogenesis, mitochondrial dynamics, mitophagy and the mitochondrial unfolded protein response. New and powerful phenotypic assays in cell-based models as well as multicellular organisms have been developed to explore these different aspects of mitochondrial function. Modulating mitochondrial function has therefore emerged as an attractive therapeutic strategy for several diseases, which has spurred active drug discovery efforts in this area.

摘要

线粒体功能障碍不仅是罕见遗传性线粒体疾病的标志,而且与年龄相关的疾病有关,包括影响代谢和神经系统的疾病,如 2 型糖尿病和帕金森病。许多途径可维持和/或恢复适当的线粒体功能,包括线粒体生物发生、线粒体动力学、线粒体自噬和线粒体未折叠蛋白反应。已经开发出基于细胞模型以及多细胞生物的新型强大表型测定法来探索线粒体功能的这些不同方面。因此,调节线粒体功能已成为几种疾病的有吸引力的治疗策略,这促使该领域积极开展药物发现工作。

相似文献

1
Pharmacological approaches to restore mitochondrial function.
Nat Rev Drug Discov. 2013 Jun;12(6):465-83. doi: 10.1038/nrd4023. Epub 2013 May 13.
2
Mitochondrial biogenesis: pharmacological approaches.
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
3
Targeted drug delivery to mammalian mitochondria in living cells.
Expert Opin Drug Deliv. 2005 Jan;2(1):89-102. doi: 10.1517/17425247.2.1.89.
5
Mitochondria as a therapeutic target for common pathologies.
Nat Rev Drug Discov. 2018 Dec;17(12):865-886. doi: 10.1038/nrd.2018.174. Epub 2018 Nov 5.
6
Mitophagy in neurodegeneration: an opportunity for therapy?
Curr Drug Targets. 2011 Jun;12(6):790-9. doi: 10.2174/138945011795528813.
7
Targeting drugs to mitochondria.
Eur J Pharm Biopharm. 2012 Sep;82(1):1-18. doi: 10.1016/j.ejpb.2012.05.014. Epub 2012 Jun 9.
9
Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?
Biochem Soc Trans. 2018 Aug 20;46(4):891-909. doi: 10.1042/BST20170501. Epub 2018 Jul 19.
10
The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.
Biochim Biophys Acta. 2014 Jan;1842(1):7-21. doi: 10.1016/j.bbadis.2013.10.003. Epub 2013 Oct 11.

引用本文的文献

1
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons.
Antioxidants (Basel). 2025 Aug 12;14(8):987. doi: 10.3390/antiox14080987.
2
Genetic mapping of lifespan and mitochondrial stress response in C. elegans.
Res Sq. 2025 Jul 31:rs.3.rs-7093535. doi: 10.21203/rs.3.rs-7093535/v1.
3
Piperine Enhances Mitochondrial Biogenesis to Mitigate Stress in SH-SY5Y Neuroblastoma Cells.
Food Sci Nutr. 2025 Jul 16;13(7):e70637. doi: 10.1002/fsn3.70637. eCollection 2025 Jul.
4
Genetic mapping of lifespan and mitochondrial stress response in .
bioRxiv. 2025 Jun 26:2025.06.26.661693. doi: 10.1101/2025.06.26.661693.
5
Extracellular vesicle-mediated mitochondria delivery: Premise and promise.
J Cereb Blood Flow Metab. 2025 Jun 11:271678X251349304. doi: 10.1177/0271678X251349304.
8
Ginsenoside-Re-rich ethanol extract of Panax ginseng berry enhances healthspan extension via mitostasis and NAD metabolism.
J Ginseng Res. 2025 Jan;49(1):92-102. doi: 10.1016/j.jgr.2024.11.002. Epub 2024 Nov 28.
9
Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.
Antioxidants (Basel). 2025 Jan 18;14(1):108. doi: 10.3390/antiox14010108.
10
Inter- and intracellular mitochondrial communication: signaling hubs in aging and age-related diseases.
Cell Mol Biol Lett. 2024 Dec 18;29(1):153. doi: 10.1186/s11658-024-00669-4.

本文引用的文献

1
Mitonuclear protein imbalance as a conserved longevity mechanism.
Nature. 2013 May 23;497(7450):451-7. doi: 10.1038/nature12188.
2
Evidence for a common mechanism of SIRT1 regulation by allosteric activators.
Science. 2013 Mar 8;339(6124):1216-9. doi: 10.1126/science.1231097.
3
A systems approach for decoding mitochondrial retrograde signaling pathways.
Sci Signal. 2013 Feb 26;6(264):rs4. doi: 10.1126/scisignal.2003266.
4
Humanin: a harbinger of mitochondrial-derived peptides?
Trends Endocrinol Metab. 2013 May;24(5):222-8. doi: 10.1016/j.tem.2013.01.005. Epub 2013 Feb 8.
5
Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries.
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1407-11. doi: 10.1016/j.bmcl.2012.12.076. Epub 2013 Jan 5.
8
Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance.
Cell Metab. 2012 Dec 5;16(6):765-76. doi: 10.1016/j.cmet.2012.10.016. Epub 2012 Nov 15.
9
Mitochondrial disorders as windows into an ancient organelle.
Nature. 2012 Nov 15;491(7424):374-83. doi: 10.1038/nature11707.
10
Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.
Cell Metab. 2012 Nov 7;16(5):658-64. doi: 10.1016/j.cmet.2012.09.015. Epub 2012 Oct 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验